- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-178/17: Order of the General Court of 18 January 2018 — W&O medical esthetics GmbH v EUIPO — Fidia farmaceutici (HYALSTYLE) (EU trade mark — Invalidity proceedings — EU word mark HYALSTYLE — Bad faith — Article 52(1)(b) of Regulation (EC) No 207/2009 (now Article 59(1)(b) of Regulation (EU) 2017/1001) — Request for the hearing of witnesses — Article 75 of Regulation (EC) No 207/2009 (now Article 94(1) of Regulation (EU) 2017/1001) — Action in part manifestly inadmissible and in part manifestly unfounded in law)
ECLI:EU:UNKNOWN:62017TB0178
62017TB0178
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
12.3.2018
Official Journal of the European Union
C 94/27
(Case T-178/17)(1)
((EU trade mark - Invalidity proceedings - EU word mark HYALSTYLE - Bad faith - Article 52(1)(b) of Regulation (EC) No 207/2009 (now Article 59(1)(b) of Regulation (EU) 2017/1001) - Request for the hearing of witnesses - Article 75 of Regulation (EC) No 207/2009 (now Article 94(1) of Regulation (EU) 2017/1001) - Action in part manifestly inadmissible and in part manifestly unfounded in law))
(2018/C 094/36)
Language of the case: English
Parties
Applicant: W&O medical esthetics GmbH (Oberursel, Germany) (represented by: A. Finkentey, lawyer)
Defendant: European Union Intellectual Property Office (represented by: A. Söder, acting as Agent)
Other party to the proceedings before the Board of Appeal of EUIPO intervening before the General Court: Fidia farmaceutici SpA (Abano Terme, Italy) (represented by: R. Kunz-Hallstein and H. Kunz-Hallstein, lawyers)
Re:
Action brought against the decision of the First Board of Appeal of EUIPO of 17 January 2017 (Case R 872/2016-1), relating to invalidity proceedings between W&O medical esthetics and Fidia farmaceutici.
Operative part of the order
1.The action is dismissed.
2.W&O medical esthetics GmbH shall bear its own costs and those of the European Union Intellectual Property Office (EUIPO) and of Fidia farmaceutici SpA.
OJ C 144, 8.5.2017.
* * *